Olga Rojas

10 June 2021
711 Views

Dr. Olga Rojas MD, PhD

Scientist, UHN-Krembil Research Institute
Assistant Professor, Department of Immunology, University of Toronto

Dr. Rojas received an MD degree from Pontificia Universidad Javeriana in Colombia by 2001. Then she pursued her PhD in Colombia, South America in 2007 studying the mucosal immune response against Rotavirus in humans. In 2010 she started a post-doctoral fellowship followed by a Research associate position at Dr. Jennifer Gommerman Lab, Department of Immunology- University of Toronto studying the role of Intestinal B cells and Plasma cells in Multiple Sclerosis. During that time, Dr. Rojas was able to show that a small subset of IgA Plasma Cells (IgA-PC) that were initially primed in the gut by the microbiota could migrate to the brain to regulate neuroinflammation in Multiple sclerosis (MS) and Experimental Acute Encephalomyelitis (EAE). Once intestinal IgA PC reach the inflamed brain, they produce IL10 to dampen the disease.

By the end of 2020, Dr. Rojas joined UHN-Krembil Research Institute as a Scientist.  As an early career investigator, her lab is interested in understanding the role of mucosal immune cells as a key intermediate of the gut-brain axis during neuroinflammation and aging-related neurological disorders. Central to this question is understanding how changes in the adaptive immune response at the brain-meningeal border can modulate neurodegeneration. More specifically, She is interested at dissecting the possible role of intestinal-derived immune cells as key players in the gut-brain axis and how those cells can directly (by migration) or indirectly (by cytokines, chemokines) impact pathogenic processes in the brain during neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s Disease with the goal of developing novel therapeutic strategies.

You may be interested

Library
96 views

Animal Models

stine - 27 September 2022

[memberonly]Linking Human Diseases to Animal Models Using. Ontology-Based Phenotype AnnotationFrom jcb.rupress.org on December 2, 2009Toll-like receptor 4 and high-mobility group…

16th ISNI Congress – Quebec City, Canada
Next congresses
372 views
Next congresses
372 views

16th ISNI Congress – Quebec City, Canada

stine - 27 September 2022

16th ISNI Congress & 4th GSNI Pre-Congress Course - 20-24 August 2023 in Quebec City, Canada

9th European Stroke Organisation Conference
News
154 views
News
154 views

9th European Stroke Organisation Conference

stine - 16 September 2022

The 9th European Stroke Organization Conference (ESOC) will take place in Munich, Germany from May 24-26, 2023. MORE INFORMATION CLICK HERE